R2LCMV-E7E6/IMMUNOGENIC
UNII Z2X598W2ZH

Substance Identification & Data

This profile provides standardized clinical and technical data for R2lcmv-e7e6/immunogenic, uniquely identified by the FDA Unique Ingredient Identifier (UNII) Z2X598W2ZH.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
Z2X598W2ZH
CAS Registry Number
N/A
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
R2LCMV-E7E6/IMMUNOGENIC
Official standardized name for this substance within the FDA UNII nomenclature system.
Substance Type
structurallyDiverse
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for R2lcmv-e7e6/immunogenic. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

R2LCMV-E7E6 (L-SEGMENT AND THE S-SEGMENT WITH LCMV NP AND THE MUTANT E7E6 FUSION PROTEIN/IMMUNOGENIC)
R2LCMV-E7E6/IMMUNOGENIC
RNA (LYMPHOCYTIC CHORIOMENINGITIS VIRUS VECTOR HB-201 SEGMENT L), SUPRAMOLECULAR COMPLEX WITH RNA (LYMPHOCYTIC CHORIOMENINGITIS VIRUS VECTOR HB-201 SEGMENT S-1 HUMAN PAPILLOMAVIRUS 16 (24-GLYCINE,26-GLYCINE,91-GLYCINE) GENE E7 PROTEIN FUSION PROTEIN WITH (69-GLYCINE,112-GLYCINE) GENE E6 PROTEIN TRANSGENE PLUS NUCLEOCAPSID PROTEIN-SPECIFYING)

External Clinical & Regulatory Resources

NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record